Literature DB >> 9860977

A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.

E M Garabedian1, P A Humphrey, J I Gordon.   

Abstract

A transgenic mouse model of metastatic prostate cancer has been developed that is 100% penetrant in multiple pedigrees. Nucleotides -6500 to +34 of the mouse cryptdin-2 gene were used to direct expression of simian virus 40 T antigen to a subset of neuroendocrine cells in all lobes of the FVB/N mouse prostate. Transgene expression is initiated between 7 and 8 weeks of age and leads to development of prostatic intraepithelial neoplasia within a week. Prostatic intraepithelial neoplasia progresses rapidly to local invasion. Metastases to lymph nodes, liver, lung, and bone are common by 6 months. Tumorigenesis is not dependent on androgens. This model indicates that the neuroendocrine cell lineage of the prostate is exquisitely sensitive to transformation and provides insights about the significance of neuroendocrine differentiation in human prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860977      PMCID: PMC28051          DOI: 10.1073/pnas.95.26.15382

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Neuro-endocrine cells--a new prognostic parameter in prostate cancer.

Authors:  R J Cohen; G Glezerson; Z Haffejee
Journal:  Br J Urol       Date:  1991-09

2.  The proliferative function of basal cells in the normal and hyperplastic human prostate.

Authors:  H Bonkhoff; U Stein; K Remberger
Journal:  Prostate       Date:  1994       Impact factor: 4.104

3.  The neuroendocrine cell population of the human prostate gland.

Authors:  R J Cohen; G Glezerson; L F Taylor; H A Grundle; J H Naudé
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

4.  Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases.

Authors:  B Têtu; J Y Ro; A G Ayala; D E Johnson; C J Logothetis; N G Ordonez
Journal:  Cancer       Date:  1987-05-15       Impact factor: 6.860

5.  Bombesin stimulates growth of human prostatic cancer cells in vitro.

Authors:  M Bologna; C Festuccia; P Muzi; L Biordi; M Ciomei
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

6.  Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients.

Authors:  G V Shah; W Rayford; M J Noble; M Austenfeld; J Weigel; S Vamos; W K Mebust
Journal:  Endocrinology       Date:  1994-02       Impact factor: 4.736

7.  Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers.

Authors:  H Bonkhoff; U Stein; K Remberger
Journal:  Hum Pathol       Date:  1994-01       Impact factor: 3.466

8.  Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate.

Authors:  H Bonkhoff; U Stein; K Remberger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Elevated plasma chromogranin-A concentrations in prostatic carcinoma.

Authors:  D Kadmon; T C Thompson; G R Lynch; P T Scardino
Journal:  J Urol       Date:  1991-08       Impact factor: 7.450

Review 10.  Neuroendocrine differentiation in human prostatic carcinoma.

Authors:  P A di Sant'Agnese
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

View more
  47 in total

Review 1.  Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Authors:  Fang Qi; Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

2.  Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model.

Authors:  G Wu; Lei Yu; L Wang; H Wang; J W Xuan
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

3.  A graphical user interface for a comparative anatomy information system: design, implementation and usage scenarios.

Authors:  Ravensara S Travillian; Kremena Diatchka; Tejinder K Judge; Katarzyna Wilamowska; Linda G Shapiro
Journal:  AMIA Annu Symp Proc       Date:  2006

Review 4.  Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathology.

Authors:  Peter Swindle; Saadallah Ramadan; Peter Stanwell; Simon McCredie; Peter Russell; Carolyn Mountford
Journal:  MAGMA       Date:  2008-09-17       Impact factor: 2.310

Review 5.  The genomic revolution and endocrine pathology.

Authors:  Suzana S Couto; Robert D Cardiff
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 6.  Mouse models of prostate cancer: picking the best model for the question.

Authors:  Magdalena M Grabowska; David J DeGraff; Xiuping Yu; Ren Jie Jin; Zhenbang Chen; Alexander D Borowsky; Robert J Matusik
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

7.  Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.

Authors:  Laurie E Littlepage; Mark D Sternlicht; Nathalie Rougier; Joanna Phillips; Eugenio Gallo; Ying Yu; Kurt Williams; Audrey Brenot; Jeffrey I Gordon; Zena Werb
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

8.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Prostatic intraepithelial neoplasia in genetically engineered mice.

Authors:  Jae-Hak Park; Judy E Walls; Jose J Galvez; Minjung Kim; Cory Abate-Shen; Michael M Shen; Robert D Cardiff
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 10.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.